PortalPublikationenEpidemiology, Comorbidity and Risk Factors for Psoriatic Art...

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis

Standard

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis. / Reinhardt, Maximilian; Garbe, Claudia; Petersen, Jana; Augustin, Matthias; Kirsten, Natalia; Biermann, Mona; Häberle, Benjamin; Hagenström, Kristina.

in: ACTA DERM-VENEREOL, Jahrgang 101, Nr. 10, 11.10.2021, S. adv00566.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Reinhardt, M, Garbe, C, Petersen, J, Augustin, M, Kirsten, N, Biermann, M, Häberle, B & Hagenström, K 2021, 'Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis', ACTA DERM-VENEREOL, Jg. 101, Nr. 10, S. adv00566. https://doi.org/10.2340/00015555-3879

APA

Reinhardt, M., Garbe, C., Petersen, J., Augustin, M., Kirsten, N., Biermann, M., Häberle, B., & Hagenström, K. (2021). Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis. ACTA DERM-VENEREOL, 101(10), adv00566. https://doi.org/10.2340/00015555-3879

Vancouver

Reinhardt M, Garbe C, Petersen J, Augustin M, Kirsten N, Biermann M et al. Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis. ACTA DERM-VENEREOL. 2021 Okt 11;101(10):adv00566. https://doi.org/10.2340/00015555-3879

Bibtex

@article{f45b2313c465419487600b0f5dd44130,
title = "Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis",
abstract = "Psoriatic arthritis is a frequent manifestation of pso­riasis, and has a high level of impact on physical func­tioning, work ability and quality of life. However, there have been few studies of the epidemiology, de­velopment of and risk factors for concomitant psoriatic arthritis in patients with psoriasis. This study analysed data from a German public health insurance database of > 2 million individuals. Factors influencing the de­velopment of psoriatic arthritis were determined by descriptively analysing comorbidities and Cox regres­sion modelling. The prevalences of psoriasis and pso­riatic arthritis were 2.63% and 0.29% in adults (18+ years) and, respectively, 0.30% and 0.01% in child­ren (0–17 years). The proportion of adult patients with incident psoriasis who developed concomitant psoriatic arthritis within five years after diagnosis of psoriasis (mean 2.3 years) was 2.6%. Cardiovascular diseases are the most frequent comorbidity in patients with psoriasis with or without concomitant psoriatic arthritis. Depression and neurosis/stress disorder were identified as indicators for the development of psoriatic arthritis.",
author = "Maximilian Reinhardt and Claudia Garbe and Jana Petersen and Matthias Augustin and Natalia Kirsten and Mona Biermann and Benjamin H{\"a}berle and Kristina Hagenstr{\"o}m",
year = "2021",
month = oct,
day = "11",
doi = "10.2340/00015555-3879",
language = "English",
volume = "101",
pages = "adv00566",
journal = "ACTA DERM-VENEREOL",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "10",

}

RIS

TY - JOUR

T1 - Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: a Health Insurance Claims Database Analysis

AU - Reinhardt, Maximilian

AU - Garbe, Claudia

AU - Petersen, Jana

AU - Augustin, Matthias

AU - Kirsten, Natalia

AU - Biermann, Mona

AU - Häberle, Benjamin

AU - Hagenström, Kristina

PY - 2021/10/11

Y1 - 2021/10/11

N2 - Psoriatic arthritis is a frequent manifestation of pso­riasis, and has a high level of impact on physical func­tioning, work ability and quality of life. However, there have been few studies of the epidemiology, de­velopment of and risk factors for concomitant psoriatic arthritis in patients with psoriasis. This study analysed data from a German public health insurance database of > 2 million individuals. Factors influencing the de­velopment of psoriatic arthritis were determined by descriptively analysing comorbidities and Cox regres­sion modelling. The prevalences of psoriasis and pso­riatic arthritis were 2.63% and 0.29% in adults (18+ years) and, respectively, 0.30% and 0.01% in child­ren (0–17 years). The proportion of adult patients with incident psoriasis who developed concomitant psoriatic arthritis within five years after diagnosis of psoriasis (mean 2.3 years) was 2.6%. Cardiovascular diseases are the most frequent comorbidity in patients with psoriasis with or without concomitant psoriatic arthritis. Depression and neurosis/stress disorder were identified as indicators for the development of psoriatic arthritis.

AB - Psoriatic arthritis is a frequent manifestation of pso­riasis, and has a high level of impact on physical func­tioning, work ability and quality of life. However, there have been few studies of the epidemiology, de­velopment of and risk factors for concomitant psoriatic arthritis in patients with psoriasis. This study analysed data from a German public health insurance database of > 2 million individuals. Factors influencing the de­velopment of psoriatic arthritis were determined by descriptively analysing comorbidities and Cox regres­sion modelling. The prevalences of psoriasis and pso­riatic arthritis were 2.63% and 0.29% in adults (18+ years) and, respectively, 0.30% and 0.01% in child­ren (0–17 years). The proportion of adult patients with incident psoriasis who developed concomitant psoriatic arthritis within five years after diagnosis of psoriasis (mean 2.3 years) was 2.6%. Cardiovascular diseases are the most frequent comorbidity in patients with psoriasis with or without concomitant psoriatic arthritis. Depression and neurosis/stress disorder were identified as indicators for the development of psoriatic arthritis.

U2 - 10.2340/00015555-3879

DO - 10.2340/00015555-3879

M3 - SCORING: Journal article

VL - 101

SP - adv00566

JO - ACTA DERM-VENEREOL

JF - ACTA DERM-VENEREOL

SN - 0001-5555

IS - 10

ER -